ELI LILLY & Co financial data

Symbol
LLY on NYSE
Industry
Pharmaceutical Preparations
Location
Lilly Corporate Ctr, Drop Code 1094, Indianapolis, IN
State of incorporation
IN
Fiscal year end
December 31
Former names
LILLY ELI & CO (to 10/25/2019), LILLY ELI & CO ET AL (to 10/14/1994)
Latest financial report
10-K - Q4 2024 - Feb 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 121 % +12.2%
Quick Ratio 28 % +17.7%
Return On Equity 76.8 % +63.6%
Return On Assets 14.6 % +60.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 948M shares
Entity Public Float 770B USD +93.3%
Common Stock, Value, Issued 592M USD -0.2%
Weighted Average Number of Shares Outstanding, Basic 901M shares +0.05%
Weighted Average Number of Shares Outstanding, Diluted 904M shares +0.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 45B USD +32%
Research and Development Expense 8.14B USD +16.4%
Nonoperating Income (Expense) -219M USD -326%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12.7B USD +93.5%
Income Tax Expense (Benefit) 2.09B USD +59.1%
Net Income (Loss) Attributable to Parent 10.6B USD +102%
Earnings Per Share, Basic 11.8 USD/shares +102%
Earnings Per Share, Diluted 11.7 USD/shares +102%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.27B USD +16%
Accounts Receivable, after Allowance for Credit Loss, Current 11B USD +21.1%
Inventory, Net 7.59B USD +31.5%
Other Assets, Current 111M USD -25.5%
Assets, Current 32.7B USD +27.3%
Deferred Income Tax Assets, Net 8B USD +46.1%
Property, Plant and Equipment, Net 17.1B USD +32.4%
Operating Lease, Right-of-Use Asset 1.05B USD +2.53%
Intangible Assets, Net (Excluding Goodwill) 6.17B USD -10.7%
Goodwill 5.77B USD +16.8%
Other Assets, Noncurrent 5.72B USD +14.6%
Assets 78.7B USD +23%
Accounts Payable, Current 3.23B USD +24.2%
Employee-related Liabilities, Current 2.09B USD +26.9%
Liabilities, Current 28.4B USD +3.97%
Accrued Income Taxes, Noncurrent 4.06B USD +5.5%
Operating Lease, Liability, Noncurrent 971M USD +2.36%
Other Liabilities, Noncurrent 2.18B USD -2.79%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.32B USD +0.12%
Retained Earnings (Accumulated Deficit) 13.5B USD +31.3%
Stockholders' Equity Attributable to Parent 14.2B USD +31.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 14.3B USD +31.4%
Liabilities and Equity 78.7B USD +23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.17B USD -32.6%
Net Cash Provided by (Used in) Financing Activities -311M USD -176%
Net Cash Provided by (Used in) Investing Activities -1.18B USD -71%
Common Stock, Shares Authorized 3.2B shares 0%
Common Stock, Shares, Issued 948M shares -0.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -358M USD -124%
Deferred Tax Assets, Valuation Allowance 964M USD +5.5%
Deferred Tax Assets, Gross 12.4B USD +20.5%
Operating Lease, Liability 1.15B USD +3.54%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 10.6B USD +123%
Lessee, Operating Lease, Liability, to be Paid 1.45B USD +3.94%
Property, Plant and Equipment, Gross 28.9B USD +20.3%
Operating Lease, Liability, Current 176M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 189M USD +4.94%
Lessee, Operating Lease, Liability, to be Paid, Year One 221M USD +12.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 300M USD +5.48%
Lessee, Operating Lease, Liability, to be Paid, Year Three 172M USD +11.9%
Deferred Tax Assets, Operating Loss Carryforwards 587M USD +11.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.98B USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 130M USD -5.72%
Depreciation, Depletion and Amortization 401M USD +10.6%
Deferred Tax Assets, Net of Valuation Allowance 11.5B USD +22%
Interest Expense 563M USD +61%